Professional Documents
Culture Documents
Caroline H. Bueno1; Duziene D. Pereira2; Marcos P. Pattussi3; Patrícia K. Grossi4, Márcio L. Grossi5
1
DDS, MS, Post-Graduate Program in Dentistry (Prosthodontics), Faculty of Dentistry, Pontifical
Pontifical Catholic University of Rio Grande do Sul (PUCRS), Post-Graduate Program in Dentistry
(Prosthodontics), Brazil.
3
DDS, MSc, PhD , Post-Graduate Program in Public Health, Vale do Rio dos Sinos University
(UNISINOS), Brazil.
4
BSW, MSW, PhD, Post-Graduate Program in Social Work, School of Humanities, Pontifical Catholic
Corresponding author: Prof. M. L. Grossi. Faculty of Dentistry, Pontifical Catholic University of Rio
Grande do Sul (PUCRS), Brazil. Address: Faculdade de Odontologia – PUCRS, Avenida Ipiranga
This article has been accepted for publication and undergone full peer review but has not been
through the copyediting, typesetting, pagination and proofreading process, which may lead to
differences between this version and the Version of Record. Please cite this article as doi:
10.1111/joor.12661
This article is protected by copyright. All rights reserved.
ABSTRACT
Accepted Article
The objective of this study was to systematically evaluate gender differences in the prevalence of
duplicate by two independent reviewers. The inclusion criteria were cross-sectional studies that
reported the prevalence of TMD for men and women and that used the RDC/TMD Axis I group
III=arthralgias/arthritis/arthrosis).To be eligible for inclusion, studies must include adult individuals (>18
years) from a non-clinical population (i.e.,without pre-diagnosis of TMD);in other words, from
population-based studies.There were no restrictions on the year and language of publication. The
quality of the articles was assessed by an adapted version of the Newcastle-Ottawa Scale(NOS), and
the publication bias was assessed by a funnel plot graph. Data were quantitatively analyzed by meta-
analysis using odds ratio (OR) as the measure effect. The electronic search retrieved a total of 6,104
articles, of which 112 articles were selected for full-text reading according to the eligibility criteria. By
means of manual search, one study was retrieved. Five articles were selected for meta-analysis with a
combined sample of 2,518 subjects.Women had higher prevalence of TMD in all RDC/TMD diagnostic
groups. The meta-analysis yielded the following results:a) OR=2.24 for global TMD (groups I, II and III
combined), b) OR=2.09 for group I, c) OR=1.6 for group II,and d) OR=2.08 for group III. The
importance of gender in the development of TMD has been demonstrated,with a two-times greater risk
Keywords: temporomandibular joint disorders; orofacial pain; gender identity; epidemiology; review;
meta-analysis.
BACKGROUND
Gender serves as an important determinant of health and plays an etiological role in the
tend to show more signs and symptoms of TMD and to seek treatment more frequently as compared
revealed that 36.2% of the population had some degree of pain and temporomandibular dysfunction,
and that 5.1% of the individuals presented with severe limitation due to pain. They have also found
that the prevalence of TMD is usually more common in young adults, in low income individuals, and in
women5. Another study has investigated the prevalence of TMD related symptoms in subjects in their
fifties in Sweden6. They have found that the prevalence of TMD pain was almost twice as frequent in
women (12.7%) as in men (6.7%); and they have also identified bruxism, impaired masticatory
efficiency, and gender as the most significant risk factors for the development of TMD6. On the other
hand, the Orofacial Pain Prospective Evaluation and Risk Assessment (OPPERA) prospective cohort
study, which monitored 2,737 men and women aged 18 to 44 years, recruited at four U.S. study sites
during 2.8 years, has found that gender differences played a minor role in the early onset of signs and
The literature so far has presented gender differences as secondary findings or has reported it
only as part of the study population description, using clinically-based samples and non-validated TMD
questionnaires8. Therefore, a more detailed analysis of the distribution of TMD diagnoses by gender is
necessary to better quantify these differences. Thus, the main objective of this study was to evaluate
the existence of gender differences in TMD from population-based studies which used the
Axes I and/or II, the present TMD examination and diagnosis gold standard. The secondary objectives
were to assess these differences according to the RDC/TMD Axis I group diagnostic criteria: a) muscle
group III. The global TMD assessment was a combination of groups I, II, and III. In addition, our
results would be discussed briefly against the gender distribution in both large sample
This is a systematic literature review followed by a meta-analysis. The protocol of this study
was registered in the PROSPERO database (2016: CRD42016039209). The project was approved by
the Scientific and Ethics Committee at the Pontifical Catholic University of Rio Grande do Sul Faculty
of Dentistry (2016: CCEFO/PUCRS, #7211), City of Porto Alegre, State of Rio Grande do Sul, Brazil.
Research question
The PICOT question format was used, where "P" is the population or problem of interest, "I" is
the intervention under investigation or variable of interest, "C" is the comparison of interest, "O" is
considered the research outcome when evaluating the results, and "T" is the type of study22. The
research question developed is: “Is there a gender difference in the development of
temporomandibular disorders in the adult population?”; where: P = adult population (≥18 years), I =
female gender, C = male gender, O = pain / dysfunction, and T = cross-sectional and observational
studies.9,10
To be included in this systematic review, studies must have reported the prevalence of TMD
for both men and women and must have used the RDC/TMD as the diagnostic tool. In addition, to be
eligible, studies must have also included adult individuals (> 18 years), from populations of non-clinical
origin without a pre-diagnosis of TMD; that is, they must be population-based studies. There were no
Case-studies, literature reviews, case series, letters to the editor, editorials, comments, short
communications, clinical trials, as well as cohort, case-control, and in vitro studies were excluded.
Studies in which the outcome/disease was not TMD (e.g., headaches, neuropathic facial pain, lip and
cleft palate patients, etc.); studies in which patients underwent orthodontic treatment, surgery, and
other treatments for TMD (e.g., oral splints, medications, physiotherapy); studies in which patients had
a history of facial trauma or rheumatic diseases; and studies in which patients originated from specific
A search was conducted using both DeCS (Biochemistry Health Sciences Descriptors) and
MeSH (Medical Subject Heading of MEDLINE) terms as well as the most used descriptors of
published scientific papers related to the subject. Thus, the following terms were used in the
joint dysfunction syndrome, temporomandibular disorder(s), temporomandibular joint, gender, sex, and
epidemiology.
Different combinations of these search terms were used according to the formatting of each
database. The Boolean terms "AND" and "OR" were used to cross search terms among each other in
order to enlarge (OR) or to restrict (AND) the search spectrum. The search was carried out by two
reviewers (i.e., a master's and a doctoral student) in a duplicate and independent manner (i.e., same
search was conducted twice by each reviewer). The electronic search strategy was performed as
OR “Temporomandibular joint”) AND (gender OR sex OR epidemiology). The final number of articles
found in each database was the following: a) PUBMED/MEDLINE = 2,198, b) EMBASE = 2,254, c)
LILACS = 231, and d) WEB OF SCIENCE = 1,421. In an effort to search for the gray literature, the
databases NDLTD / Global EDT Search, BDTD - Bank of Theses and Dissertations of CAPES, Open
The results of the electronic search were exported to the EndNote Web program (Thomson
Reuters®, New York, USA). A database was created in the program, where it was possible to store, to
organize, and to select the articles. Prior to selecting the articles themselves, articles in duplicate were
eliminated by the program as well as manually. The selection of the articles was carried out in two
phases: a) phase I: reading and selection of the relevant articles through titles and abstracts by two
phase II: analysis by complete reading of the article by two independent reviewers, with the need for
Accepted Article
agreement of both reviewers to include/exclude the study, and in case of disagreement, consensus
In the second phase, articles which did not meet the inclusion criteria were excluded, and the
reasons were described in a table. To obtain articles selected for complete reading that were not
available in full text, an attempt was made to contact the authors to request them. After completing the
full-text article analysis, the data obtained from those articles which met the inclusion criteria were
transferred to an Excel worksheet (Microsoft Office®, Microsoft, Redmond, USA). In this worksheet, all
relevant information in each article has been noted. The “Cochrane Handbook for Systematic
Reviews”9 and the “Strobe initiative: guidelines on reporting observational studies”10 were used to build
this worksheet.
The data collected were: a) general information about the study (i.e., title, year and publication
period, first author, and country(ies) of origin); b) information about the study methods (i.e.,
duration/follow-up of the study, place of the study, study design, diagnostic criteria used to define the
condition of interest, and methods of data collection); c) information about the study sample (i.e.,
source and method of sample selection, sample size, sample age, and sample distribution by gender);
information (i.e., statistical methods employed, such as odds ratio and standard error).
To evaluate the quality of the articles, the Newcastle - Ottawa Scale (NOS) was used. The
questionnaire works by means of a "star system" (i.e., a star is awarded for each quality item, which
serves as a quick visual assessment, with a maximum seven stars) used to classify prevalence
studies. In the study selection questionnaire, a study is graded into three major topics: a) the selection
of the study groups; b) the comparability of groups; and c) the verification of the exposure/outcome of
interest11. The study selection questionnaire was applied to each of the articles selected for full-text
reading analysis, in a duplicate and independent manner by the two reviewers. Afterwards, a
consensus was reached, and the final result of the quality of each article was obtained.
low, by combining the results in a meta-analysis and presenting them in a forest plot chart. The
Accepted Article
measure of effect used was the odds ratio (OR), since the outcome was dichotomous. The effect
model used was the fixed one due to the absence of heterogeneity. The statistical method employed
was the Mantel-Haenszel. The statistical program used for data analysis and graphing was the Review
Manager (RevMan Computer program. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The
Cochrane Collaboration, 2014). The heterogeneity was analyzed by means of the I2 inconsistency test,
also present in the Review Manager program. The I2 assigns a value from 0 to 100%, and this
percentage shows how much of the difference between the studies can be explained by
heterogeneity, and not by chance. It is standardly considered that 0-25% has a low heterogeneity, 25-
75% has an intermediate heterogeneity, and above 75% has a high heterogeneity12. Studies with
positive results are more likely to be published, therefore an analysis is important to verify the
presence or absence of publication biases. For this purpose, a visual analysis with a funnel plot graph
(Software Review Manager) was performed. The presence of asymmetry will lead us to question the
interpretation of the global estimate of effect when the studies are combined in a meta-analysis13.
RESULTS
The literature search resulted in 6,104 articles, which yielded a total of 3,418 initial records
after duplicated items were removed. The first screening excluded 3,306 results leaving 112 articles
for full reading. One additional article was included after manual search in these articles’ references.
After reading the full texts, five articles were selected for inclusion in the study, yielding a total sample
size of 2,518 subjects. The sequence of identification, selection of studies and reasons for exclusion
can be seen in detail in Figure 1, and the detailed description of these selected studies were
presented in Table I.
Most of the studies were published in the last five years, and only one in the last 15 years. The
place of studies was divided between Europe and Latin America. Two used both axes of the
RDC/TMD questionnaire (i.e., Axes I and II) for the patient evaluation, and the other three used only
Axis I. Most of them were performed in young adult patients, and one study14 evaluated the elderly
groups. Men presented higher prevalence of TMD in group I only in Martínez et al. (2013)15, and in
group II in Martínez et al. (2013)15 and Sandoval et al. (2015)14. Group III had higher prevalence rates
Accepted Article
for women in all studies. In the global prevalence of TMD (i.e., groups I, II, and III combined), all
studies have shown higher TMD prevalence for women (Table II).
Meta-analysis
The meta-analysis was performed for each diagnostic group (i.e., groups I, II and III) of the
RDC/TMD Axis I and also for the global results of the TMD prevalence (i.e., all groups combined).
Figure 2a shows the global prevalence of TMD among genders, and there was a highly statistically
significant difference in the prevalence of TMD between men and women (P < 0.00001). The odds for
presenting TMD was 2.2 times higher in women as compared to men. There was no heterogeneity
The meta-analysis performed individually for groups I, II and III of the RDC/TMD is presented
in Figures 2b, 2c and 2d; respectively. There was a statistically significant difference for all TMD
diagnostic groups. The OR has shown us that women are 2.08 times more likely to present muscle
disorders; 1.6 times more likely to have disc displacements; and 2.09 times more likely to have
arthralgia/arthritis/osteoarthrosis than men. The heterogeneity was moderate (i.e., 45%) among the
studies for group I; and low (i.e., 12% and 0%) for groups II and III, respectively.
Publication Bias
The search for publication bias was performed with a Funnel Plot graph. In Figure 3, it can be
observed that the graph found in this study, due to its symmetry, suggests that there is no publication
Quality of studies
The qualitative analysis of the included studies can be observed in Table III. Overall, all the
studies have presented good quality assessment, having 2 articles with a maximum star evaluation
(i.e., 7 stars), two with six stars, and only one with 5 stars.
than men, an important factor when planning treatment and prevention programs16; although it is
possible to notice that the difference was relatively smaller in group II (disc displacements) than in
both groups I (muscular disorders) and III (arthralgia/arthritis/osteoarthrosis). However, the OPPERA
study, which was not included in this study for not using the RDC/TMD, has confirmed the growing
gender difference with time, as the incidence of TMD observed was 3.9% per year (i.e., 3.6% for
women and 2.8% for men) for 2.8 years with 2,737 participants, producing mild to moderate levels of
pain and disability in all cases17. The difference between the relative risk in the OPPERA study (RR =
1.37) and ours (OR = 2.2) might be attributed to the fact that RR is calculated based on TMD
incidence, while the OR is based on TMD prevalence16, which is higher according the RDC/TMD
However, it is not yet clear what aspects of women's biology, psychology, or social roles
predispose them of having more TMD than men. The differences between the genders might be
related to hormonal factors18-20, cultural and social factors21,22, higher levels of work stress for
psychiatric disorders are similar between men and women, the kind of disorders differ. Depression and
anxiety affect women almost twice as often as men2. Since patients with depression are at high risk of
developing TMD27,28, this could be one explanation for the differences found between the genders in
TMD. Using the conclusions from the OPPERA study, self-rated general health conditions (i.e.,
apnea, cigarette smoking, and previous surgeries and hospitalizations), general chronic pain disorders
(i.e., low back and genital pain, irritable bowel syndrome, migraine and tension-type headaches), age,
study site, ethnicity (i.e., African or Asian descendants), and psychosocial and genetic factors seem to
play an equal or more important role than gender. The study has concluded that TMD is a complex
biopsychosocial condition and can no longer be considered a localized orofacial pain condition17. That
said, it seems urgent and relevant to study and investigate why women are more affected by TMD,
since such clarification might bring a more complete clinical approach to these treatments.
RDC/TMD questionnaire29 was to allow the standardization and unification of TMD diagnoses and a
Accepted Article
better comparison among the study results, considering that only the RDC/TMD has been translated
and validated in many different languages30. Therefore, it is suggested in future studies, the
In a meta-analysis, it was found that the prevalence of treatment need for TMD in adults was
16.2% and that the study location strongly influenced the summary estimates of the treatment need31.
Indeed, this result contrasts with another Brazilian study by Progiante et al, 2015; which found that
only 5% of the population were in need of TMD treatment.5 Our meta-analysis selected studies from
Latin-America as well as from Eastern and Western Europe; and here too, the study location might
have influenced the different prevalences for men and women found among the selected studies in
our systematic review (Table II) and meta-analysis (Figures 2a, 2b, 2c, and 2d). Therefore, as a
limitation of our study, we should consider the confounding factors specific to the studies that were
selected, such as: the country of study and the methodology applied by single or multiple examiners
which were not considered in our final analysis. The lack of reported data regarding the RDC/TMD
sub-groups in TMD gender prevalence in the literature (i.e., groups Ia, Ib, IIa, IIb, IIc, IIIa, IIIb and IIIc)
for our data collection and meta-analysis was also a limitation. Another issue is the very few studies
selected (only five) which reported primary non-clinical TMD population (i.e., without a prior TMD
diagnosis) and that used the RDC/TMD, which was our main inclusion criteria. The analysis ended
with no study reporting the TMD prevalence in Asia, Africa and North America; only in Europe and
Latin America. However, another study not included in our analysis for not using the RDC/TMD,
reported the prevalence of facial pain and TMD in people from urban and rural areas in Iran. It
evaluated, by means of logistic regression analysis, the influence of potential TMD risk factors such
as: education, gender, health, and the environment. Their results, similar to our global TMD OR = 2.2,
have shown that gender was also an important risk factor with OR = 2.28.32
Another limitation of our study was the fact that we have included a predominantly young adult
population (i.e., 4 out of 5 studies selected) with a mean age ranging from 22 to 46 years. The only
study with an older population was from Sandoval et al, with a mean age of 67 years old, but with a
results are valid predominantly for the young adult age group; and conclusions for other age groups,
Accepted Article
such as adolescents and the elderly population, should be performed in specific systematic reviews.
However, a brief discussion of the adolescent age group only will be detailed below, considering that
the elderly group comprises a small portion of patients seeking TMD treatment.5
Regarding adolescence, TMD is more prevalent in adolescents. There has been some recent
TMD prevalence studies in adolescents with large samples (n = 934 – 1,307) from the general
population.34,35,36,37 The methodology has been heterogenous, but most of them recruit subjects from
public schools, between the ages of 10 up to 18, and they use the RDC/TMD Axis I for the clinical
examination with a combination of a simple screening questionnaire (i.e., the American Academy
Orofacial Pain - AAOP or the Helkimo Index modified by Fonseca); the Axis II is hardly ever used, or
used partially with few questions.34,35,36,37,38 Using this methodology, the prevalence of TMD symptoms
has been high and varied (25.2% - 34.9%), but with a predominance of myofascial pain diagnosis
(10.3% - 15.4%).34,35,36,37 Disc displacement with reduction (4.8% - 8.0%) was also frequent; while
arthralgia was rarely diagnosed (3.3% - 3.5%), similar to osteoarthritis (0.0% - 0.2%) and
osteoarthrosis (1.5% - 2.2%).34,35 Despite the variation observed among studies, most of them have
reported that the majority of the sample with TMD symptoms studied were women (61.2%-63.1%),
keeping the odds in approximately 2:1; similarly to what has been reported in adult populational
studies and in this meta-analysis.5,35,37 However, few studies have actually measured gender as a risk
factor for TMD in this age group; in one study, the authors have found a 37% increase in prevalence
ratio in women for developing TMD symptoms, 76% increase for developing myofascial pain, and
106% increase for developing disc displacement with reduction.35 In another study, the authors have
found a 30% increase in odds ratio for developing TMD symptoms, 50% increase for myofascial pain,
20% increase for disc displacement with reduction, but no difference for arthralgia or osteoarthrosis.34
These results are similar to what was reported in this meta-analysis. As explained before, screening
questionnaires (i.e.; AAOP and the Helkimo index modified by Fonseca) have been used frequently in
the literature in this age group; however, a study has found low sensitivity in both questionnaires for
the detection of TMD symptoms, despite showing a high specificity in children and adolescents. In
addition, the authors have also found low levels of agreement in both screening questionnaires
against the TMD clinical exam.39 Therefore, the results from these screening questionnaires must be
TMD pain intensity and disability assessment) are rare, and it is unknown if these adolescents with
Accepted Article
signs and symptoms of TMD are in fact in need of treatment. These two measurements, pain intensity
versus disability (i.e., GCPS=I,II,III,IV versus GCPS=III,IV), have been shown to give very different
prevalences in the adult population (i.e., 36.2% versus 5.1%).5 As an example, only one study that
used the GCPS has shown that only 6.5% of the adolescents with TMD symptoms were included in
Grades=III,IV and were in fact in need of treatment, but 27.2% of them had TMD symptoms.34 It is
important to emphasize that both the RDC/TMD Axis I and the modified Axis II have already been
tested for reliability in this age group, with results ranging from acceptable to excellent in Axis I, and
from good to excellent in the modified Axis II.40 It is not known also if these signs and symptoms are
self-limiting once the growth spurt finishes, or if in fact they will increase after puberty. One single
three-year longitudinal study, which used the GCPS, reported an incidence of TMD symptoms of 4.5%
for girls and 1.3% for boys. They also compared teenagers with 12-15 against those with 13-19 years
of age. They have found significant differences in all TMD pain and psychosocial measures and have
concluded that TMD pain increases with age; and that TMD pain seems to have a greater impact on
girls rather than boys, particularly between 16 to 19 years of age.41 Therefore, more longitudinal
studies with the validated RDC/TMD Axis I and II, or with the newly developed DC/TMD, are still
clinical) patients which have also used the RDC/TMD Axis I or II within the last 10 years, we have
found interesting results. The sample among the reviewed studies have ranged from 308 to 3,263
TMD patients, the mean age has varied from 19 to 44 years, and the proportion of women has varied
from 57.3% 88%.43-52 This yields odds ranging approximately from 3:1 to 9:1, which is substantially
larger than what we have found among non-TMD population-based sample in this study; i.e., odds of
2:1. This can be explained due to the fact that patients seeking treatment have usually higher TMD
pain and disability levels than what has been found in the non-clinical population; and the increase in
pain levels seems to affect women more than men, not only in the adult, but also in adolescent
population.1-4,41
than two times the risk of developing TMD. However, other equally important factors reported in the
recent literature must be also taken into account, such as: self-rated general health conditions, general
chronic pain disorders, age, study site, ethnicity, and psychosocial and genetic factors.
ACKNOWLEDGMENTS
This project was approved by PUCRS Faculty of Dentistry (Project #7211) Ethics Committee,
Brazil. This research received no specific grant from any funding agency in the public, commercial, or
not-for-profit sectors. The authors declare that they have no conflicts of interest.
REFERENCES
1. Niessen LC, Gibson G, Kinnunen TH. Women’s Oral Health: Why Sex and Gender Matter.
2. Goldman MB, Hatch MC. Women and Health. New York: Academic Press/Elsevier, 2000:15-
25;50-80.
3. Shaefer JR, Holland N, Whelan JS, Velly AM. Pain and Temporomandibular Disorders: A
2015;385:10.
5. Progiante PS, Pattussi MP, Lawrence HP, Goya S, Grossi PK, Grossi ML. Prevalence of
Pain. 2003;17:29-35.
7. Sanders AE, Slade GD, Bair E, Fillingim RB, Knott C, Dubner R, Greenspan JD, Maixner W,
10. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke
Epidemiol. 1998;61:344-9.
11. Wells, GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-
Ottawa Scale (NOS) for assessing the quality of non randomized studies in meta-analyses.
12. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-
13. Egger M, Smith GD, Altman DG. Systematic Reviews in Health Care: A Practical Guide:
15. Martínez CC, Santillana IEA, Lavín AMW, Tostado FL. Prevalence of temporomandibular
16. Antunes JLF, Peres MA. Epidemiologia da Saúde Bucal. Rio de Janeiro: Guanabara Koogan,
2006:237-250.
17. Slade GD, Bair E, Greenspan JD, Dubner R, Fillingim RB, Diatchenko L, Maixner W, Knott
18. Martin VT. Ovarian hormones and pain response: a review of clinical and basic science
19. Turner JA. Targeting temporomandibular disorder pain treatment to hormonal fluctuations: A
20. Vilanova LSR, Gonçalves TM, Meirelles L, Garcia RC. Hormonal Fluctuations Intensify
2015;28:72-4.
21. Al-Harthy M, Ohrbach R, Michelotti A, List T. The effect of culture on pain sensitivity. J Oral
Rehabil. 2016;43:81-8.
22. Pow EHN, Leung KC, McMillan AS. Prevalence of Symptoms Associated with
part 1: are there really differences between women and men? Pain 2012;153:602-18.
25. Shinal RM, Fillingim RB. Overview of Orofacial Pain: Epidemiology and Gender Differences in
27. Fillingim RB, Ohrbach R, Greenspan JD, Knott C, Diatchenko L, Dubner R, Bair E, Baraian
28. Liao C, Chang CS, Chang SN, Lane HY, Lyu SY, Morisky DE, Sung FC. The risk of
29. Dworkin SF, Leresche L. Research diagnostic criteria for temporomandibular disorders:
Disord. 1992;6:301-55.
2014;472346:1-7.
Accepted Article
31. Al-Jundi MA, John MT, Setz JM, Szentpétery A, Kuss O. Meta-analysis of Treatment Need for
Disorders: Samples Taken From Attendees of Medical Health-Care Centers in the Islamic
33. Rantala MA, Ahlberg J, Suvinen TI, Savolainen A, Könönen M. Symptoms, Signs, and Clinical
35. Bertoli FMP, Bruzamolin CD, Pizzatto E, Losso EM, Brancher JA, de Souza JF. Prevalence of
36. Fernandes G, van Selms MK, Goncalves DA, Lobbezoo F, Camparis CM. Factors associated
39. Santis TO, Motta LJ, Biasotto-Gonzalez DA, Mesquita-Ferrari RA, Fernandes KP, Godoy CH,
et al. Accuracy study of the main screening tools for temporomandibular disorder in children
51.
41. Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, et al. International
Rdc/Tmd Consortium Network IafDR, Orofacial Pain Special Interest Group IAftSoP.
Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research
Orofacial Pain Special Interest Group. J Oral Facial Pain Headache. 2014;28:6-27.
42. Nilsson IM. Reliability, validity, incidence and impact of temporomandibular pain disorders in
students of Babol University of Medical Sciences and Technology, Iran. J Oral Health Oral
Epidemiol 2015;4:94-101.
impairment of individuals suffering from different types of chronic orofacial pain. Prog Orthod.
2014;15:27.
Mack N, Slade GD, Maixner W. Psychological factors associated with development of TMD:
Accepted Article
the OPPERA prospective cohort study. J Pain. 2013;14:T75-90.
46. Huang GJ, LeResche L, Critchlow CW, Martin MD, Drangsholt MT. Risk factors for diagnostic
a population of patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol
Dent. 2010;38:765-72.
49. Reissmann DR, John MT, Seedorf H, Doering S, Schierz O. Temporomandibular disorder pain
is related to the general disposition to be anxious. J Oral Facial Pain Headache. 2014;28:322-
30.
the research diagnostic criteria for temporomandibular disorders. J Oral Facial Pain
Headache. 2015;29:135-43.
51. Velly AM, Look JO, Carlson C, Lenton PA, Kang W, Holcroft CA, Fricton JR. The effect of
gender using the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) Axis I by
Accepted Article
diagnostic group individually and by all diagnostic groups combined.
* GI or group I = muscle disorders; GII or group II = disc displacements; GIII or group III =
Table III. Result of the quality evaluation of the five selected studies which used the Research
Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) Axis I (groups I, II and III) to assess
Martínez et al.15 6
Progiante et al.5 7
Rantala et al.33 7
Sandoval et al.14 5
Wieckiewicz et al.30 6
Instrument: The Newcastle - Ottawa Scale (NOS). Maximum of 7 stars can be awarded to a study.
Figure: 2a. Forest plot of the odds ratios for global prevalence of temporomandibular disorders
(RDC/TMD Axis I: groups I, II and III) in women versus men. 2b. Forest plot of odds ratios (OR) for
muscle disorders (RDC/TMD, Axis I, group I) in women versus men. 2c. Forest plot of the odds ratios
for disk displacements (RDC/TMD, Axis I, group II) in women versus men. 2d. Forest plot of the odds
ratios for arthralgia/arthritis/arthrosis (RDC/TMD, Axis I, group III) in women versus men.
Figure 3. Funnel Plot of selected studies which used the Research Diagnostic Criteria for
Temporomandibular Disorders (RDC/TMD) Axis I (groups I, II and III) to assess the prevalence of